Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

ACT-385781A (Actelion Epoprostenol)
(D00106)

[1] Epoprostenol

[1] Epoprostenol (D00106) 💬

[1] PTGIR 💬

[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬

[1] 86 💬

2

Current marketed FLOLAN (epoprostenol sodium)
(D00106)

[1] Epoprostenol

[1] Epoprostenol (D00106) 💬

[1] PTGIR 💬

[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬

[1] 86 💬

3

EPOPROSTENOL
(D00106)

[1] Epoprostenol

[1] Epoprostenol (D00106) 💬

[1] PTGIR 💬

[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬

[1] 86 💬

4

Epoprostenol for injection
(D00106)

[1] Epoprostenol

[1] Epoprostenol (D00106) 💬

[1] PTGIR 💬

[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬

[1] 86 💬

5

EPOPROSTENOL SODICO
(D00106)

[1] Epoprostenol

[1] Epoprostenol (D00106) 💬

[1] PTGIR 💬

[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬

[1] 86 💬

6

EPOPROSTENOL SODIUM
(D00106)

[1] Epoprostenol

[1] Epoprostenol (D00106) 💬

[1] PTGIR 💬

[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬

[1] 86 💬

7

Epoprostenol-Actelion
(D00106)

[1] Epoprostenol

[1] Epoprostenol (D00106) 💬

[1] PTGIR 💬

[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬

[1] 86 💬

8

New thermo stable formulation of epoprostenol sodium
(D00106)

[1] Epoprostenol

[1] Epoprostenol (D00106) 💬

[1] PTGIR 💬

[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬

[1] 86 💬